MDT and patient perspectives on new and emerging therapies for HFrEF
touchMDT for touchCARDIO
Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss established therapies for HFrEF and key efficacy and safety considerations for new and emerging therapies
The multidisciplinary team
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//
It is Free